Search

Your search keyword '"Chilcott RP"' showing total 62 results

Search Constraints

Start Over You searched for: Author "Chilcott RP" Remove constraint Author: "Chilcott RP"
62 results on '"Chilcott RP"'

Search Results

1. The percutaneous toxicokinetics of Sulphur mustard in a damaged skin porcine model and the evaluation of WoundStat™ as a topical decontaminant

3. Clinical manifestations of VX poisoning following percutaneous exposure in the domestic white pig.

4. Topically Applied Therapies for the Treatment of Skin Disease: Past, Present, and Future.

5. Evaluation of emergency skin decontamination protocols in response to an acid attack (vitreolage).

6. Exposure to organophosphorus compounds: best practice in managing timely, effective emergency responses.

7. Illicit COVID-19 products online: A mixed-method approach for identifying and preventing online health risks.

8. A Fatal Case Report of Barium Chloride Toxicity.

9. Profiling the vendors of COVID-19 related product on the Darknet: An observational study.

10. Quantifying the Risk to Health Care Workers of Cough as an Aerosol Generating Event in an Ambulance Setting: A Research Report.

11. SARS-CoV-2: characterisation and mitigation of risks associated with aerosol generating procedures in dental practices.

12. Efficacy of Different Hair and Skin Decontamination Strategies with Identification of Associated Hazards to First Responders.

13. Decontamination and Management of Contaminated Hair following a CBRN or HazMat Incident.

15. Evaluation of US Federal Guidelines (Primary Response Incident Scene Management [PRISM]) for Mass Decontamination of Casualties During the Initial Operational Response to a Chemical Incident.

16. UK's initial operational response and specialist operational response to CBRN and HazMat incidents: a primer on decontamination protocols for healthcare professionals.

17. Further studies of the efficacy of military, commercial and novel skin decontaminants against the chemical warfare agents sulphur Mustard, Soman and VX.

18. Optimization of Nonambulant Mass Casualty Decontamination Protocols as Part of an Initial or Specialist Operational Response to Chemical Incidents.

19. Hybrid in vitro diffusion cell for simultaneous evaluation of hair and skin decontamination: temporal distribution of chemical contaminants.

20. Sebomic identification of sex- and ethnicity-specific variations in residual skin surface components (RSSC) for bio-monitoring or forensic applications.

21. The percutaneous absorption of soman in a damaged skin porcine model and the evaluation of WoundStat™ as a topical decontaminant.

22. Eyeing up the Future of the Pupillary Light Reflex in Neurodiagnostics.

23. The percutaneous toxicokinetics of VX in a damaged skin porcine model and the evaluation of WoundStat™ as a topical decontaminant.

24. Evaluation of a new topical skin protectant (RD1433) for the prevention and treatment of incontinence-associated dermatitis.

25. The percutaneous toxicokinetics of Sulphur mustard in a damaged skin porcine model and the evaluation of WoundStat™ as a topical decontaminant.

26. Application of sebomics for the analysis of residual skin surface components to detect potential biomarkers of type-1 diabetes mellitus.

27. Development of haemostatic decontaminants for treatment of wounds contaminated with chemical warfare agents. 3: Evaluation of in vitro topical decontamination efficacy using damaged skin.

28. Volunteer trials of a novel improvised dry decontamination protocol for use during mass casualty incidents as part of the UK'S Initial Operational Response (IOR).

29. Evaluation of absorbent materials for use as ad hoc dry decontaminants during mass casualty incidents as part of the UK's Initial Operational Response (IOR).

30. Mass Casualty Decontamination in the United States: An Online Survey of Current Practice.

31. Preliminary evaluation of military, commercial and novel skin decontamination products against a chemical warfare agent simulant (methyl salicylate).

32. Development of haemostatic decontaminants for the treatment of wounds contaminated with chemical warfare agents. 1: evaluation of in vitro clotting efficacy in the presence of certain contaminants.

33. Development of haemostatic decontaminants for the treatment of wounds contaminated with chemical warfare agents. 2: evaluation of in vitro topical decontamination efficacy using undamaged skin.

34. Development of a cumulative irritation model for incontinence-associated dermatitis.

35. Optimisation of a dosing regime for a topical skin protectant (barrier cream).

36. Managing mass casualties and decontamination.

37. Design and characterisation of a novel in vitro skin diffusion cell system for assessing mass casualty decontamination systems.

38. Effect of ethnicity, gender and age on the amount and composition of residual skin surface components derived from sebum, sweat and epidermal lipids.

39. In vivo decontamination of the nerve agent VX using the domestic swine model.

40. Ga(III) complexes--the effect of metal coordination on potential systemic absorption after topical exposure.

41. Comparative analysis of showering protocols for mass-casualty decontamination.

42. The skin reservoir of sulphur mustard.

43. Evaluation of barrier creams against sulphur mustard: (II) In vivo and in vitro studies using the domestic white pig.

44. Absorption of the nerve agent VX (O-ethyl-S-[2(di-isopropylamino)ethyl] methyl phosphonothioate) through pig, human and guinea pig skin in vitro.

45. Closed cup vapor systems in percutaneous exposure studies: what is the dose?

46. Evaluation of a barrier cream against the chemical warfare agent VX using the domestic white pig.

47. In vivo skin absorption and distribution of the nerve agent VX (O-ethyl-S-[2(diisopropylamino)ethyl] methylphosphonothioate) in the domestic white pig.

48. Toxicity of sulphur mustard.

49. Inter- and intralaboratory variation of in vitro diffusion cell measurements: an international multicenter study using quasi-standardized methods and materials.

50. Wound healing of cutaneous sulfur mustard injuries: strategies for the development of improved therapies.

Catalog

Books, media, physical & digital resources